Besca Mark 4

What Happened Mark Besca, a director of Clarus Corporation (CLAR), received a derivative award on 2026-05-28: options covering 20,000 shares of Clarus common stock. The grant is reported as an award (transaction code A) — no cash was paid at grant. The filing lists the award amount and vesting schedule; the exercise price is not specified in the excerpt provided.

Key Details

• Transaction date: 2026-05-28; Form filed: 2026-06-01 (see full filing for timeliness details).
• Award: Options to acquire 20,000 shares (derivative instrument); reported acquisition price listed as $0.00 (reflecting an award, not a cash purchase).
• Vesting: 5,000 options vest and become exercisable on each of June 30, 2026; September 30, 2026; December 31, 2026; and March 31, 2027 (per filing footnote).
• Transaction code: A = award/grant.
• Shares owned after transaction: not specified in the provided excerpt — check the full Form 4 for post-transaction holdings.
• Footnote: Grant made under the Issuer’s Amended and Restated 2015 Stock Incentive Plan.

Context This was an equity compensation grant (options) to a director, which is a common form of executive/director compensation and not the same as an outright purchase or sale. Options vest over time; until vested and exercised, they do not represent freely tradable shares. For full details (including exercise price, any acceleration or forfeiture conditions, and exact post-transaction holdings), consult the complete Form 4 filing (Accession No. 0001104659-26-068928).